HRT Financial’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.06M Buy
+88,043
New +$5.73M 0.02% 825
2026
Q1
– Sell
-73,127
Closed -$2.32M – 4761
2025
Q4
$2.32M Buy
+73,127
New +$2.28M 0.01% 1214
2025
Q3
– Sell
-15,434
Closed -$567K – 3700
2025
Q2
$567K Buy
+15,434
New +$533K ﹤0.01% 1540
2025
Q1
– Sell
-24,174
Closed -$1.12M – 3418
2024
Q4
$1.12M Sell
24,174
-6,171
-20% -$279K 0.01% 1017
2024
Q3
$1.37M Buy
+30,345
New +$1.44M 0.01% 1062
2024
Q2
– Sell
-23,970
Closed -$822K – 3134
2024
Q1
$822K Sell
23,970
-22,394
-48% -$808K 0.01% 980
2023
Q4
$1.71M Sell
46,364
-7,533
-14% -$174K 0.01% 726
2023
Q3
$1.09M Buy
53,897
+13,685
+34% +$301K 0.01% 923
2023
Q2
$822K Buy
+40,212
New +$602K 0.01% 1069
2022
Q4
– Sell
-59,536
Closed -$2.1M – 3169
2022
Q3
$2.1M Buy
+59,536
New +$2.53M 0.02% 584
2022
Q1
– Sell
-14,077
Closed -$1.09M – 3881
2021
Q4
$1.09M Buy
+14,077
New +$1.44M 0.01% 1035
2021
Q1
– Sell
-25,292
Closed -$3.57M – 3160
2020
Q4
$3.57M Buy
+25,292
New +$2.81M 0.07% 201

Other funds holding TWST

HRT Financial's TWST Position: Q2 2026 in Review

HRT Financial opened a new position in Twist Bioscience (TWST) in Q2 2026: 88,043 shares worth $9.06M. The stake represents 0.02% of the portfolio and ranks #825 among its holdings. This is a return to the name: HRT Financial previously reported a position in TWST as recently as Q4 2025.

HRT Financial first reported a position in TWST in Q4 2020 and has held it in 12 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • HRT Financial held 88,043 shares of Twist Bioscience worth $9.06M as of Q2 2026.
  • Twist Bioscience was a new HRT Financial position in Q2 2026.
  • Twist Bioscience made up 0.02% of HRT Financial's portfolio in Q2 2026, its #825 holding.
  • HRT Financial first reported a position in Twist Bioscience in Q4 2020 and has held it in 12 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.